Genetic lesions can be either be global (e.g. Tp53 knockout) or targeted to a particular tissue or cell type (e.g. Pdx1-Cre in the KPC mouse model of pancreatic cancer). This evidence concerns the gene TP53 and familial pancreatic carcinoma.